Sciencepulse

The Scientist Who Mapped the Migraine Brain

Science·November 7, 2026

The Scientist Who Mapped the Migraine Brain

Throbbing pain, nausea, dizziness and visual disturbances. Anyone who has lived through a migraine knows how disabling it can be, and far more people live with the condition than most realise. Migraine affects more people than diabetes, epilepsy and asthma combined. For decades, though, doctors understood little about the brain activity behind an attack, and the drugs available often failed the patients who needed them most.

Peter Goadsby, Professor of Neurology at King's College London's Institute of Psychiatry, Psychology and Neuroscience, has spent much of his career working to change that. His research helped establish what happens in the brain during a migraine, tracing the chain of events that leads to the pain. That work has moved beyond the lab. It has informed a new generation of medicines, some of which treat an attack once it begins and others that aim to prevent attacks from happening at all.

Many of these newer treatments target calcitonin gene-related peptide, or CGRP, a signalling molecule involved in migraine. Drugs that block CGRP or its receptor have given many patients options that older medicines did not, and some people who had tried multiple treatments without success have found relief. For a condition that has long been treated as a private burden, that shift matters.

The recognition now comes in the form of the Brain Prize, which is widely regarded as the world's largest award for brain research. Goadsby shares it with three other internationally respected scientists working in the field. The award highlights a broader point: research into everyday neurological conditions can be just as transformative as work on rarer or more dramatic diseases, particularly when it affects so many people.

Reporting based on an external source.